Stock Events

Stock Events

Nuo Therapeutics 

$1.2700
1
+$0.00+0%Friday 18:47

Statistics

Day High
1.28
Day Low
1.28
52W High
2.92
52W Low
0.77
Volume
100
Avg. Volume
4,490
Mkt Cap
61.49M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Dec 2Expected
Q4 2018
Q1 2019
Q2 2019
Q3 2025
Q1 2026
Q2 2026
Next
-0.03
-0.02
-0.01
-0
Expected EPS
-0.01
Actual EPS
N/A

Financials

-75.8%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
3.31MRevenue
-2.51MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap123.49B
Medtronic plc offers medical technologies, services, and solutions, including those for wound care, which directly competes with Nuo Therapeutics' wound healing products.
Stryker
SYK
Mkt Cap111.95B
Stryker Corporation specializes in medical and surgical equipment, including wound management, competing in the same healthcare space as Nuo Therapeutics.
Boston Scientific
BSX
Mkt Cap60.84B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, including wound care products.
Zimmer Biomet
ZBH
Mkt Cap16.84B
Zimmer Biomet Holdings, Inc. provides musculoskeletal healthcare products and solutions, including surgical products for wound care, competing with Nuo Therapeutics.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson engages in the research and development, manufacture, and sale of a broad range of products in the healthcare field, including wound care solutions.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie Inc. operates in the pharmaceuticals sector, offering products that could compete in the broader market for treatment solutions, including those for wound healing.
Pfizer
PFE
Mkt Cap173.95B
Pfizer Inc. is a research-based biopharmaceutical company with products that could compete in therapeutic areas, including wound healing.
Baxter International
BAX
Mkt Cap11.9B
Baxter International Inc. provides a portfolio of healthcare products, including advanced surgery products and therapies for wound healing.
AMGEN
AMGN
Mkt Cap251.94B
Amgen Inc. focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise, potentially competing in wound healing.
Gilead Sciences
GILD
Mkt Cap211.7B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that could compete indirectly through its focus on innovative therapies, including those for wound care and healing.

About

Nuo Therapeutics, Inc. operates as a regenerative medicine company, specializing in the development, commercialization, and marketing of advanced cell-based technologies. These solutions are engineered to leverage the human body's inherent capacity for natural healing, with a primary focus on the United States market. Central to their offerings is a technology that isolates components from a patient's own blood (autologous) to generate a platelet-based therapy, specifically tailored for the treatment of chronic wounds. Established in Houston, Texas, in 1998, the company underwent a name change from Cytomedix, Inc. to Nuo Therapeutics, Inc. in November 2014.
Show More
CEO
David E. Jorden
Employees
10
Country
United States
ISIN
US67059V2097

Listings

OTC Link
US
AURX

0 Comments

Share your thoughts

FAQs

What is Nuo Therapeutics stock price today?▼
The current price of AURX is $1.27 USD — it has increased by +0% in the past 24 hours. Watch Nuo Therapeutics stock price performance more closely on the chart.
What is Nuo Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Nuo Therapeutics stocks are traded under the ticker AURX.
Is Nuo Therapeutics stock price growing?▼
AURX stock has fallen by -2.31% compared to the previous week, the month change is a +1.6% rise, over the last year Nuo Therapeutics has showed a -36.5% decrease.
What is Nuo Therapeutics market cap?▼
Today Nuo Therapeutics has the market capitalization of 61.49M
When is the next Nuo Therapeutics earnings date?▼
Nuo Therapeutics is going to release the next earnings report on December 2, 2026.
What were Nuo Therapeutics earnings last quarter?▼
AURX earnings for the last quarter are -0.01 USD per share, whereas the estimation was -0.01 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Nuo Therapeutics revenue for the last year?▼
Nuo Therapeutics revenue for the last year amounts to 3.31M USD.
What is Nuo Therapeutics net income for the last year?▼
AURX net income for the last year is -2.51M USD.
How many employees does Nuo Therapeutics have?▼
As of November 2, 2026, the company has 10 employees.
In which sector is Nuo Therapeutics located?▼
Nuo Therapeutics operates in the Health & Wellness sector.
When did Nuo Therapeutics complete a stock split?▼
Nuo Therapeutics has not had any recent stock splits.
Where is Nuo Therapeutics headquartered?▼
Nuo Therapeutics is headquartered in Houston, United States.